- Q1 4
- Q2 1
- Q3 0
- Q4 0
Academician
EMİNE NUR ÖZBEK ATALAY
ARAŞTIRMA GÖREVLİSİ
EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmakoloji
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 6- i10-index
- 1
- Total citations
- 40 Top 48% in Türkiye
- Per article
- 6.7
- FWCI
- 1.55 1.00 = world average
- World top 1%
- 0
- World top 10%
- 1
Most cited articles
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. h-index on the OpenAlex author profile: 3.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #22,426/ 43,834 top 51.2%Score 5.65 journal 5.4 · OA add 0.25
- Article rank24,327/43,834
- Scopus rank22,287/43,834
- WoS rank21,266/43,834
- YÖKSİS7
- Scopus5
- WoS6
-
Side field FarmakolojiPoints rank #91/ 194 top 46.9%Score 5.65 journal 5.4 · OA add 0.25
- Article rank96/194
- Scopus rank91/194
- WoS rank90/194
- YÖKSİS7
- Scopus5
- WoS6
Index quartiles
?- Q1 2
- Q2 3
- Q3 0
- Q4 1
1 articles
- Top 1% 0
- Top 10% 1
- Avg 68.7%
- n 6
Other counts
Scopus (SJR)
- YÖKSİS rows 5
WoS (JCR)
- YÖKSİS rows 6
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
7 journals
Article list
- 2025 Empagliflozin Protects Against Oxidative Stress in the Diabetic Brain by Inducing H(2)S Formation. YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.1%
- 2025 In Vitro Drug Release Kinetics and Antioxidant Activity of Metformin-Loaded Niosomes YÖKSİS SJR Q1 JCR Q2 OpenAlex 79.9%
- 2025 Borax pentahydrate as a promising boron-based angiogenesis inhibitor. YÖKSİS SJR Q1 JCR Q2 OpenAlex 75.7%
- 2023 Pharmacological modulation of vascular ageing: A review from VascAgeNet YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.9%
- 2023 The Effects of Novel Triazolopyrimidine Derivatives on H2S Production in Lung and Vascular Tonus in Aorta. YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.7%
- 2020 Drug Repurposing in the Treatment of COVID-19 YÖKSİS TR Index JCR Q4
- 2020 Ticari Değere Sahip Tıbbi ve Aromatik Bitkisel DroglarMedicinal and Aromatic Herbal Drogs with Commercial Value YÖKSİS OpenAlex 20.7%